<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Mon, 02 Jun 2025 14:52:59 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Tolebrutinib not superior to teriflunomide in reducing relapsing multiple sclerosis relapse rates</title><link>https://www.2minutemedicine.com/tolebrutinib-not-superior-to-teriflunomide-in-reducing-relapsing-multiple-sclerosis-relapse-rates/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2019/09/multiple-sclerosis-300x150.jpg</image_url><description>1. In concurrent randomized controlled trials (GEMINI 1 and GEMINI 2) of patients with relapsing multiple sclerosis (RMS), tolebrutinib did not signif...</description><pubDate>Mon, 02 Jun 2025 18:00:53 GMT</pubDate></item><item><title>#VisualAbstract: Navigational Bronchoscopy is Noninferior to Transthoracic Needle Biopsy for Diagnostic Accuracy in Lung Nodules</title><link>https://www.2minutemedicine.com/visualabstract-navigational-bronchoscopy-is-noninferior-to-transthoracic-needle-biopsy-for-diagnostic-accuracy-in-lung-nodules/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/2MM_05.19.25_Astrid_2_LungNodules-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Mon, 02 Jun 2025 15:00:23 GMT</pubDate></item><item><title>#VisualAbstract: As-Needed Albuterol-Budesonide is Effective in Mild Asthma</title><link>https://www.2minutemedicine.com/visualabstract-as-needed-albuterol-budesonide-is-effective-in-mild-asthma/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/2MM_VA_20may2025-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Mon, 02 Jun 2025 15:00:12 GMT</pubDate></item><item><title>Mixed reality exposure therapy may have a role in obsessive-compulsive disorder</title><link>https://www.2minutemedicine.com/mixed-reality-exposure-therapy-may-have-a-role-in-obsessive-compulsive-disorder/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2017/12/doctor-patient-7-300x150.png</image_url><description>1. In this randomized clinical trial, mixed reality exposure and response prevention (MERP) was a feasible treatment for contamination obsessive-compu...</description><pubDate>Mon, 02 Jun 2025 00:00:02 GMT</pubDate></item><item><title>Incidence and prevalence of dementia among US Medicare beneficiaries between 2015 – 2021</title><link>https://www.2minutemedicine.com/incidence-and-prevalence-of-dementia-among-us-medicare-beneficiaries-between-2015-2021/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2019/10/brain-neuro-dementia-PD-300x150.jpg</image_url><description>1. In this cohort of older adults, the overall incidence of dementia decreased from 2015 to 2021, however, the prevalence increased. Evidence Rating L...</description><pubDate>Sun, 01 Jun 2025 00:00:59 GMT</pubDate></item></channel></rss>